Table

References
 
 

Characteristics of studies with interventions aimed at smoking cessation [as supplied by author]
 

Study detailsInterventionsResults*
Berman (1995), USA, community setting. N=348. Low-to-middle income multi-ethnic smoking adults within an inner-city school district.

Mean age: 36.7 years, 50.9% female.

A 12-month study to test the effectiveness of a preventative health programme featuring smoking cessation tailored to an under-served, multi-ethnic (Latino and African-American) adult population of smokers.

I: Received health education materials targeting cardiovascular risk factors, and invited to participate in a seven-session (1.5 hours per session) smoking-cessation group class conducted after the 6-month follow-up. Brief, tailored smoking cessation booster messages were delivered at the end of 3- and 6-month interviews, based on point-prevalence smoking status and history. Also received a tailored support letter based on smoking status, referring to specific sections of the smoking-cessation materials. 

C: Received health education materials targeting cardiovascular risk factors.

Smoking cessation: no significant differences between intervention groups at final follow-up.

Stage movement: Not reported.

Butler (1999), UK, primary care setting. N=536. Smokers consulting a General Practitioner in South Wales. Mean age: 41 years; 70% female.A 6-month study to compare the clinical and cost-effectiveness of motivational consulting with brief advice to quit smoking.

I: Motivational consulting is based on inviting patients to numerically rate their motivation and confidence to quit smoking (phase 1). Clinicians respond to these scores using specific questions and strategies (phase 2). The aim is to build motivation or confidence by encouraging the patient to identify arguments for change (motivation) or practical, attainable steps for quitting (confidence). Finally, patients are invited to set meaningful targets for themselves (phase 3).

C: Brief Advice consisted of the following statement: "Smoking is an extremely serious matter. Apart from lung cancer, smoking can damage your health in many other ways. If you give up now, a lot of the harm can be undone. It is my professional duty to tell you that you must give up smoking in the interest of your future health."

Smoking cessation: No significant differences between groups for scores on self-reported abstinence in the previous month, three measures for quit attempts, and numbers of cigarettes cut down. Significant differences for scores on self-reported abstinence in the previous 24 hours and the number of respondents who smoked within 5 minutes after awakening were found favouring the stage based intervention.

Stage movement: A linear trend was found after six months for stage movement favouring the stage based intervention.

Cornuz (2002), Switzerland, Outpatient clinic setting.

N=251. Current regular smokers attending an internal medicine clinic (consecutive patients). Mean age: 36 year, 40 % female.

A 12 months cluster randomised controlled trial to assess the efficacy of an educational programme based on behavioural theory, active learning methods, and practice with standardised patients in helping patients abstain from smoking and changing physician’s counselling practices.

I: A training programme administered over 2 half-days, during which physicians learned to provide counselling that matched smokers motivation to quit and practiced these skills with standardised patients acting as smokers at different stages of change.

C: A didactic session (half-day course) on management of dyslipidemia.

Smoking cessation (stage based versus non-smoking intervention): At 1-year follow-up, 1-week smoking abstinence was significantly higher in I than C (Odds Ratio=2.8, 95% Confidence Interval: 1.4, 5.5). Smokers willing to quit: I=94% (95% Confidence Interval: 89%, 99%), C=80% (95% Confidence Interval: 70%, 89%); P=0.007. 

Stage movement (stage based versus non-smoking intervention): No significant differences between groups in the proportion of smokers in precontemplation stage; or proportion moving one stage forward.

DiClemente (1991), USA, community setting. N=1758.

Volunteers responding to newspaper, radio and other media advertisements.

Mean age: 40 years, 62% female

A 6-month study to test the transtheoretical model of change that posits a series of stages through which smokers move as they successfully change the smoking habit.

I1: Based on their pretest scores, participants were sent the manual matched to their individual stage of change and manuals for all subsequent stages (5 manuals: 1-Precontemplation; 2-Contemplation; 3-Action; 4-Maintenance; and 5-Relapse). 

I2: Transtheoretical manuals and individualised written feedback (a series of 3 computer-generated reports) based on pretest, posttest, and 6-month questionnaires.

I3: Transtheoretical manuals and individualised written feedback plus a series of 4 personalised counsellor calls (following a protocol for social support in stressful decisions) at pre-test, post-test, 3 months, and 6 months. The telephone counselling protocols were stage matched and basically followed the outline of the expert system reports. 

C: American Cancer Society/American Lung Association materials and manuals.

Smoking cessation: Significantly better results for the stage based interventions (I1, I2 and I3) at six, 12 and 18 months follow-up.

Stage movement: Not reported.

Dijkstra (1999), Netherlands, community setting. N=843.

Cigarette smokers with low readiness to change, recruited by newspaper advertisements.

Mean age 41.7 years, 62.8% female

A 7-month study to investigate the efficacy of two different tailored smoking cessation self-help interventions and one standardised smoking cessation self-help guide compared to a no-information control group and with each other.

I1: Tailored intervention. Computerised system used to generate three consecutive tailored letters. 

I2: Tailored intervention. Computerised system used to generate a single tailored letter. 

I3: Self-help guide. 46-page colour self-help manual developed for use in a community smoking cessation project. 

C: no information.

Smoking cessation: no significant differences between intervention groups at final follow-up; (stage based versus no information): no significant differences between intervention groups at final follow-up.

Stage movement: A significant effect of one stage based intervention (I1) compared to the non-stage based intervention (I3) for ‘immotives’ but not for ‘precontemplators’. The other stage based intervention (I2) showed no differences in stage movement compared to the non-stage based intervention (I3) for ‘immotives’ and ‘precontemplators’; (stage based versus no information): A significant effect of both stage based interventions (I1and I2) compared to the usual care control group (C) for ‘immotives’ but not for ‘precontemplators’.

Emmons (2001), USA, Community setting (recruited through primary care settings). N=279. Smoking parents/caregivers in low-income families with young children (< 3 years). Mean age: 28 years, 92 % female.A 6-months randomised controlled trial to determine whether a motivational intervention for smoking parents of young children will lead to reduced household passive smoke exposure.

I: Motivational Intervention. A 30- to 45-minutes Motivational Intervention -session at the participant’s home with a trained health educator and 4 follow-up telephone counselling calls. With feedback from baseline household nicotine assessments and participant’s carbon monoxide level.

C: Self-help comparison condition. Participants received a copy of the smoking cessation manual, the passive smoke reduction tip sheet, and the resource guide in the mail.

Smoking cessation: The 6-month nicotine levels were significantly lower in I compared to C households. There were no significant differences in cessation rates, and no change in smoking rate between conditions at any of the follow-ups. 

Stage movement: Not reported.

Etter (2001), Switzerland, Community setting. N=2934. Daily smokers randomly selected from a general population register. Mean age: 36 years, 52 % female.A 7 months randomised controlled trial to test the effectiveness of a new computer-tailored smoking cessation programme versus no intervention. 

I: Participants received by mail a computer-tailored counselling letter based on their answers to a questionnaire and stage based booklets. The counselling letters were tailored to the participant’s stage of change (categorised as: precontemplation [no intention of quitting smoking in the next 6 month], contemplation [seriously considers quitting in the next 6 months], preparation [has decided to quit in the next 30 days]), level of tobacco dependence, self-efficacy, and personal characteristics. After 2 and 4 participants filled out a new questionnaire and received a new counselling letter.

C: No intervention.

Smoking cessation (stage based versus no intervention): One-month abstinence: I=5.8% ; C= 2.2% (P<0.001). One-week abstinence: I=8.0%, C=3.3% (P<0.001).

Hazard Ratio of quitting smoking in I: 2.1 (95% Confidence Interval: 1.4, 3.2). 

Stage movement (stage based versus no intervention): Not reported.

Gritz (1993), USA, out-patient clinic setting. N=186. Patients with newly diagnosed, first primary squamous cell carcinomas of the oral cavity, pharynx, and larynx.

Mean age: 57.8 years, 30.7% female.

A 12-month study to compare a state of the art provider delivered smoking cessation intervention with a usual care advice control condition.

ALL: Head and neck surgeons and maxillofacial prosthodontists deliver smoking cessation advice according to standardised protocols to surgical patients 2 to 3 days before hospital discharge and, to radiation-only patients, prior to treatment initiation.

I: The protocol then called for providers to give 6 monthly booster advice sessions to experimental participants as part of regular medical or dental post-treatment care. The 6 booster sessions consisted of debriefing respondents regarding their smoking cessation efforts prior to the visit and then tailoring advice to the respondent's current smoking status (abstainer, relapser, continuing smoker) according to the provider advice guidelines.

C: Received standardised 'usual care' advice from doctors regarding smoking and its contingent risks, as well as the benefits of cessation for head and neck cancer patients.

Smoking cessation (stage based versus usual care): no significant differences between intervention groups at final follow-up.

Stage movement (stage based versus usual care): Not reported.

Lennox (1998), UK, primary care setting. N=1693. Adult smokers on the participating practices' lists. Mean age and % female: not stated.A 14-month study to assess the effects of training (one-day stages of change workshop for health professionals) on patient smoking outcomes.

I: Smoking education by trained health professionals.

C: Smoking education by untrained controls.

Smoking cessation: no significant differences between intervention groups at final follow-up.

Stage movement: no significant differences between groups.

Lennox (2001), UK, Primary care setting. N=2553. Smokers registered at primary care practices. Mean age and % female: not stated.A 6 months randomised controlled trial to compare the effect (clinical and cost effectiveness) on smoking cessation of a computer tailored letter, a non-tailored letter, and no letter.

I1: Tailored letter: computerised system for generating tailored letter, based on answers in the questionnaire. System was devised by experts who were informed by their clinical experience and their knowledge of various models of behaviour change, in particular the "stage of change" model of smoking cessation. Smokers were first categorised according to their intention to stop smoking and their "decisional balance". This determined the main topics to be included in the letters.

I2: Non-tailored letter: a default tailored letter produced by scanning a blank questionnaire.

C: No letter: a letter thanking them for their participation and informing them that they would receive material at the end of the study (if either intervention worked).

Smoking cessation: Validated cessation rate at 6 months: I1=3.5% (30/857) (95% Confidence Interval: 2.3%, 4.7%), I2=4.4% (37/846) (95% Confidence Interval: 3.0%, 5.8%). No significant difference between I1 and I2.

Smoking cessation (stage based versus no intervention): Validated cessation rate at 6 months: I1=3.5% (30/857) (95% Confidence Interval: 2.3%, 4.7%), C=2.6% (22/850) (95% Confidence Interval: 1.5%, 3.7%). No significant difference between I1 and C; after adjustment for significant covariates, the cessation rate was 66% greater (4% to 186%; P=0.07) in I2 than in C.

Stage movement: Not reported. 

Stage movement (stage based versus no intervention): Not reported for total group. Among heavy smokers: I1: 76% (95% Confidence Interval: 11%, 180%) more likely positive shift than C. Among others no significant difference between I1 and C.

Morgan (1996), USA, primary care setting. N=573. Smokers visiting a primary care practice. Mean age: 60.1 years, 56% female.A 6-month study to test the effectiveness of an office-based smoking cessation programme tailored to midlife and older smokers.

I: physicians received on-site training to implement a modified National Cancer Institute smoking cessation intervention. The National Cancer Institute programme comprises 4 steps: Ask about smoking at every opportunity, Advise all smokers to stop, Assist the patient to stop smoking, and Arrange for follow-up support. 

Patients were give a copy of a smoking cessation guide tailored to older smokers ('Clear Horizons') and asked: 'If we give you some help, are you willing to try to quit?' Smokers in different stages received stage specific counselling. Smokers received a brief follow-up counselling call within 2-4 weeks of the intervention visit to reinforce their efforts, explore barriers, and discuss their quit plans.

C: delayed intervention practices were instructed to provide usual care to their older smokers over the accrual and follow-up period.

Smoking cessation (stage based versus usual care): A significant difference for quit rate favouring the stage based intervention.

Stage movement (stage based versus usual care): Not reported.

Pallonen (1994), Finland, community setting. N=265. 

Finnish men, smoking at least 10 cigarettes a day, from rural and urban settings. 

Ages: 42, 48, 54 and 60 years, 100% male.

A 2-year study to examine longitudinally how well manuals based on the transtheoretical model were accepted by smokers and to determine their efficacy in accelerating the smoking cessation process.

I: Five 10 to 20 page self-help manuals designed for each stage of change. One of these manuals corresponding to the current stage of change observed at baseline and at each follow-up assessment was mailed to a participant bi-annually after an assessment. If smoking stage did not change from one 6-month assessment to the next no manual was mailed at that time.

C: Usual care. Annual mail surveys constituted the only communication with the intervention centre.

Smoking cessation (stage based versus usual care): The study found no significant difference between groups for prolonged abstinence at 2-year follow-up, but a significant result was found for seven-day quit rate, favouring the stage based intervention.

Stage movement (stage based versus usual care): A significant effect favouring the stage based intervention for contemplators but not for ‘precontemplators’ at 1-year follow-up. At 2-year follow-up, no significant differences between groups were found.

Pallonen (1998), USA, school setting. N=135. 10th and 11th grade students, currently smoking. Mean age: 16.5 years, 40.1% femaleA 6-month study to evaluate the ability of the computer-based interventions to engage and to retain the interest of adolescents in a school setting.

I: Transtheoretical Model of Change-based expert system cessation programme. Each assessment and feedback section at each intervention session were provided in small, logically meaningful segments of the four Transtheoretical Model of Change constructs: (1) Stage of Change, (2) Decisional balance, (3) Processes of Change, and (4) Self-efficacy or Temptations to Smoke. Feedback is provided as text on the computer monitor's screen.

C: Action-orientated cessation programme; Original American Lung Association (1988) clinic program was shortened and modified into three sessions and altered for a Personal Computer monitor screen presentation. The feedback from the Action-orientated programme was predetermined and based on the assumption that the smoker was prepared to quit smoking. 

Smoking cessation: no significant differences between intervention groups at final follow-up.

Stage movement: no significant differences between intervention groups.

Pieterse (2001), Netherlands, Primary care setting. N=530. Smokers attending the General Practitioner’s practice. Mean age: 36 years, 60 % female.A 12 months randomised controlled trial to test the effectiveness of a minimal contact behavioural intervention, using the stage of change concept, for general practitioners and their practice assistants.

I: General Practitioners and practice assistant received a 2-hr skills training, with an introduction on smoking behaviour nicotine addiction, stages of change theory, and behavioural change processes. General Practitioner provides brief behavioural counselling (10 min per patient) tailored to the smokers motivational stage. Follow-up meeting is offered to smokers setting a quit date. Those wanting to quit received Nicotine chewing gum.

C: Usual treatment.

Smoking cessation (stage based versus no intervention): Abstinence at 1/6/12 months: I: 18.6%/11.9%/13.4% ; C: 3.8%/3.8%/7.3%. Abstinence at 1/12 months: Odds Ratio=2.56 (95% Confidence Interval: 1.8, 3.8)/1.51 (95% Confidence Interval: 1.1, 2.1). Consecutive abstinence at 6 and 12 months: Odds Ratio=3.04 (95% Confidence Interval: 1.7, 5.6). 

Stage movement (stage based versus no intervention): Not reported.

Pletsch (2002), USA, Out-patient clinic setting. N=74. Black pregnant women (low-income) recruited from prenatal clinics. Mean age: 24 years, 100 % female.A 3 to 9 months (depending on duration of pregnancy at start) randomised controlled trial to evaluate the effectiveness of ‘Smoke Free Families’-programme in helping pregnant women move toward becoming non-smokers and in reducing second hand smoke in the homes of low-income black families.

I: The ‘Smoke Free Families’ intervention included stage matched counselling based on processes of change, self-efficacy, family support, and pregnancy specific content. Counselling provided by registered nurses during 2 home visits. First visit: stage matched tobacco control counselling plus booklet and video. Second visit: stage of change reassessed and counselling continued. 

C: Usual prenatal care.

Smoking cessation (stage based versus no intervention): Not reported.

Stage movement (stage based versus no intervention): No significant differences between groups.

Prochaska (2001a), USA, Community setting. N=4144. Smokers recruited by random calls. Mean age: 41 years, 55% female.A 24 months randomised controlled trial to evaluate the effectiveness of a stage matched expert system.

I: Expert system, mailed materials including baseline feedback report based on baseline questionnaire and stage matched self-help manuals. At 3 and 6 months, progress questionnaires were mailed, followed by an expert progress report based on the questionnaires. N=1358.

C: Assessment only, proactively assessed at 6 month intervals. N=2786.

Smoking cessation (stage based versus no intervention): 24-hour abstinence at 6/12/18/24 months: I=9.7/18.0/21.7/ 25.6%; C=7.4/14.5/16.6/19.7%. 7-day abstinence at 6/12/18/24 months: I=9.3/17.0/20.4/24.9%; C=7.3/13.8/ 16.0/19.0%. 30-day prolonged abstinence at 6/12/18/24 months: I=6.3/13.3/19.2/23.4%; C=4.5/10.6/13.8/16.7%. 6-months prolonged abstinence at 12/18/24 months: I=4.1/8.1/ 12.0%; C=2.0/5.8/7.7%. All comparisons between groups: P<0.05.

Stage movement (stage based versus no intervention): Not reported.

Prochaska (2001b), USA, Community setting. N=1447. Smokers recruited from members of a managed care company. Mean age: 38 years, 56% female.An 18 months evaluation of an interactive expert system intervention for smoking cessation, providing individualised feedback that guides participants through the stages of change for cessation. And to test whether the intervention can be enhanced by adding proactive telephone counselling or a stimulus control computer designed to produce nicotine fading.

I1: Interactive expert system; 3 (0, 3 and 6 months) individualised computer feedback reports and a set of stage matched self-help manuals.

I2: Expert system plus counsellor calls; same as I1, plus 3 proactive counsellor calls at 0, 3 and 6 months, according to counselling protocol, based on expert system report.

I3: Expert system plus stimulus control computer; same as I1, plus smokers in contemplation and preparation stage also received Lifesign computers and instruction materials.

C: Assessment only (assessments at 0, 6, 12 and 18 months).

Smoking cessation (stage based versus no intervention): 24-hour abstinence at 6/12/18 months: I1: 16.6/20.6/23.2%; I2: 18.2/25.6/23.2%; I3: 11.3/14.1/14.6%; C: 12.1/14.4/ 17.5%. 7-day abstinence at 6/12/18 months: I1: 15.1/19.4/ 22.9%; I2: 16.7/24.7/23.2%; I3: 10.3/13.4/13.9%; C: 11.8/ 13.5/17.1%. 30-day prolonged abstinence at 6/12/18 months: I1: 12.3/17.9/21.4%; I2: 15.2/24.2/21.9%; I3: 8.6/ 1.5/11.9%; C: 8.3/12.3/14.7%. 6-month prolonged abstinence at 12/18 months: I1: 7.9/11.2%; I2: 8.5/12.3%; I3: 7.1/6.9%; C: 4.4/6.4%.

At 6 months: I1 and I2 > C and I3 (P<0.05).

At 12 months: I2 > I1> I3 and C (P<0.05), except 6 months prolonged abstinence.

At 18 months: I1 and I2 > C > I3 (P<0.05); except 6 months prolonged abstinence.

Stage movement (stage based versus no intervention): Not reported.

Reeve (2000), USA, Out-patient clinic setting. N=75. Smokers recruited from a university ambulatory clinic (staff, students and clients). Age: 8%: <24y, 51%: 24-34y, 28%: 35-44y, 12%: 45-54years, 51% female. A 3 month study to compare the effectiveness of 2 smoking cessation approaches administered by Nurse Practitioners – a stepped care approach and a routine care approach.

I: Nurse Practitioners’ procedure: determine stage of change for quitting tobacco; provide brief advise about cessation; recommend to set a quit date for those who are motivated to quit; explain about free, individualised smoking cessation counselling services available. Those interested in quitting received written health education materials; for those wanting individualised help, a health educator was available.

C: Routine care services, including: providing information about the health risks associated with using tobacco, counselling about the benefits of quitting, and discouraging the use of tobacco.

Smoking cessation: Quit at follow-up: I=3/34 (9%), C=5/41 (12%).

Stage movement: No significant differences were found between groups (data not shown).

Resnicow (1997), USA, community setting. N=1244. Low-socio-economic adult African Americans. Mean age: 45 years, 60% female.A 7-month study to test a culturally sensitive, low-intensity smoking cessation intervention.

I: "Kick IT" guide, a two-part "Kick It" video (Part 1: for precontemplators and contemplators to initiate a quit attempt, Part 2: for action and maintenance, providing instruction on how to quit, how to stay quit, and how to start over for those who did not initially succeed), a booster call (to encourage the use of intervention materials and provide brief motivational counselling), quit contract, and an invitation to enter two separate prize-draw contests - entry criteria for both was 30-day abstinence.

C: Previously developed printed health education materials related to substance use, HIV/AIDS, diet, heart disease, and cancer (but no materials that exclusively addressed tobacco use or tobacco-related cancers) and a 10-minute cholesterol education video developed for African Americans.

Smoking cessation: no significant differences between intervention groups at final follow-up. Although, a subgroup of respondents in the stage based intervention who had attended booster sessions, showed significantly better results compared to respondents in the non-stage based intervention for point prevalence quit rates and quit attempts.

Stage movement: Not reported.

Sinclair (1999), UK, primary care setting. N=474. Smokers, who either asked for advice on smoking cessation or bought an over-the-counter anti-smoking product for their own use. Mean age and % female: not stated.A 12-month study to assess the cost effectiveness of intensive pharmaceutical intervention in assisting people to stop smoking.

I: Staff from pharmacies attended 1 of 7 health promotion workshops held to explain the stage of change' model. Pharmacists tailored their advice to match the client's stage of change.

C: standard advice and support with respect to smoking cessation and nicotine replacement therapy’s.

Smoking cessation (stage based versus usual care): no significant differences between intervention groups at final follow-up.

Stage movement (stage based versus usual care): Not reported.

Stotts (2002), USA, Out-patient clinic setting. N=269. Resistant pregnant smokers recruited from 3 large multi-specialty clinics. Mean age: 28 years, 100 % female.A 13 months randomised controlled trial to determine the efficacy of an intensified, late pregnancy, smoking cessation intervention for resistant pregnant smokers.

ALL: 3-5 minutes of counselling plus a self-help booklet at first prenatal visit and 7 booklets mailed weekly thereafter. Those smoking at 28 weeks gestation randomised:

I: One 20-30 minutes telephone counselling call using Motivational Interview strategies and techniques conducted within 2 weeks; a personalised stages of change based feedback letter mailed within a week following call; a final Motivational Interview -based telephone counselling call conducted 4-5 days after feedback letter.

C: Control group, no details reported.

Smoking cessation (stage based versus no intervention): Self-reported non-smokers at 6 weeks/3 months/6 months postpartum: I: 24.1/16.9/12.2%, C: 14.6/17.1/17.1% (at 6 weeks: P<0.01). No differences between groups on 34 weeks smoking status measured via urine cotinine: I: 32%,C: 34% abstinent.

Stage movement (stage based versus no intervention): No differences by stage were found between groups.

Tappin (2000), UK, Hospital setting. N=100. Smokers recruited from a maternity hospital. Mean age: 26 years, 100 % female.A 6 months randomised controlled trial to determine whether proactive opportunistic home-based motivational interviewing (which has strategies for every stage of change) by specially trained midwives will help pregnant smokers reduce their habit. 

ALL: smoking guidance at booking at clinic.

I: A median of 4 home-based Motivational Interviewing sessions (range 2-5) from a trained midwife. ‘The strategy is matched to stage of change to help the client move on’.

C: normal care.

Smoking cessation (stage based versus no intervention): No significant differences between groups.

Stage movement (stage based versus no intervention): No differences between groups.

Wang (1994), Taiwan, primary care setting. N=82. Clinic patients who smoked at least one cigarette a day. Age: 37.6%: <40 yr, 39.8%: 40-59 yr, 22.6%: >60 yr; 4.3% female.A 6-month study to assess the feasibility and effectiveness of a stages of change model in cigarette smoking cessation counselling.

I1: Physicians were given two lectures on the stages of change model for cigarette smoking and received specific practice guidelines for clinical counselling on cigarette smoking cessation. 

I2: Physicians did not receive stages of change training but did receive a poster to be placed in the examination room to remind the doctor to conduct smoking cessation intervention in their clinic practice.

C: no intervention, i.e. physicians received no lecture, nor reminder and continued to practice in their usual style.

Smoking cessation: No significant difference between groups for scores on quit rate, but the change in daily cigarette consumption was significantly better in the stage based intervention compared to the non-stage based intervention.

Smoking cessation: (stage based versus no intervention): Significant differences between groups for scores on quit rate, and change in daily cigarette consumption favouring the stage based intervention (I1) compared to no intervention (C).

Stage movement: Not reported.

*) In the results, comparisons are between stage based interventions and non-stage based interventions unless otherwise stated.
 
 

References

w1. Berman BA, Gritz ER, Braxton Owens H, Nisenbaum R. Targeting adult smokers through a multi-ethnic public school system. J Cancer Educ 1995;10:91-101.

w2. Butler CC, Rollnick S, Cohen D, Bachmann M, Russell I, Stott N. Motivational consulting versus brief advice for smokers in general practice: a randomized trial. Br J Gen Pract 1999;49:611-6.

w3. Cornuz J, Humair JP, Seematter L, Stoianov R, van Melle G, Stalder H, et al. Efficacy of resident training in smoking cessation: a randomized, controlled trial of a program based on application of behavioral theory and practice with standardized patients. Ann Intern Med 2002;136:429-37.

w4. DiClemente CC, Prochaska JO, Fairhurst SK, Velicer WF, Velasquez MM, Rossi JS. The process of smoking cessation: an analysis of precontemplation, contemplation, and preparation stages of change. J Consult Clin Psychol 1991;59:295-304.

w5. Dijkstra A, DeVries H, Roijackers J. Targeting smokers with low readiness to change with tailored and nontailored self-help materials. Prev Med 1999;28:203-11.

w6. Emmons KM, Hammond SK, Fava JL, Velicer WF, Evans JL, Monroe AD. A randomized trial to reduce passive smoke exposure in low-income households with young children. Pediatrics 2001;108:18-24.

w7. Etter JF, Perneger TV. Effectiveness of a computer-tailored smoking cessation program: a randomized trial. Arch Intern Med 2001;161:2596-601.

w8. Gritz ER, Carr CR, Rapkin D, Abemayor E, Chang LJ, Wong WK, et al. Predictors of long-term smoking cessation in head and neck cancer patients. Cancer Epidemiol Biomarkers Prev 1993;2:261-70.

w9. Lennox AS, Bain N, Taylor RJ, McKie L, Donnan PT, Groves J. Stages of change training for opportunistic smoking intervention by the primary health care team. Part I: randomised controlled trial of the effect of training on patient smoking outcomes and health professional behaviour as recalled by patients. Health Educ J 1998;57:140-9.

w10. Lennox AS, Osman LM, Reiter E, Robertson R, Friend J, McCann I, et al. Cost effectiveness of computer tailored and non-tailored smoking cessation letters in general practice: randomised controlled trial. BMJ 2001;322:1396-400.

w11. Morgan GD, Noll EL, Orleans CT, Rimer BK, Amfoh K, Bonney G. Reaching midlife and older smokers: tailored interventions for routine medical care. Prev Med 1996;25:346-54.

w12. Pallonen UE, Leskinen L, Prochaska JO, Willey CJ, Kaariainen R, Salonen JT. A 2-year self-help smoking cessation manual intervention among middle-aged Finnish men: an application of the transtheoretical model. Prev Med 1994;23:507-14.

w13. Pallonen UE, Velicer WF, Prochaska JO, Rossi JS, Bellis JM, Tsoh JY, et al. Computer-based smoking cessation interventions in adolescents: description, feasibility, and six-month follow-up findings. Subst Use Misuse 1998;33:935-65.

w14. Pieterse ME, Seydel ER, DeVries H, Mudde AN, Kok GJ. Effectiveness of a minimal contact smoking cessation program for Dutch general practitioners: a randomized controlled trial. Prev Med 2001;32:182-90.

w15. Pletsch PK. Reduction of primary and secondary smoke exposure for low-income black pregnant women. Nurs Clin North Am 2002;37:315-29.

w16. Prochaska JO, Velicer WF, Fava JL, Rossi JS, Tsoh JY. Evaluating a population-based recruitment approach and a stage-based expert system intervention for smoking cessation. Addict Behav 2001;26:583-602.

w17. Prochaska JO, Velicer WF, Fava JL, Ruggiero L, Laforge RG, Rossi JS, et al. Counselor and stimulus control enhancements of a stage-matched expert system intervention for smokers in a managed care setting. Prev Med 2001;32:23-32.

w18. Reeve K, Calabro K, Adams McNeill J. Tobacco cessation intervention in a nurse practitioner managed clinic. J Am Acad Nurse Pract 2000;12:163-9.

w19. Resnicow K, Royce J, Vaughan R, Orlandi MA. Analysis of a multicomponent smoking cessation project: what worked and why. Prev Med 1997;26:373-81.

w20. Sinclair HK, Silcock J, Bond CM, Lennox AS, Winfield AJ. The cost-effectiveness of intensive pharmaceutical intervention in assisting people to stop smoking. Int J Pharm Pract 1999;7:107-12.

w21. Stotts AL, DiClemente CC, Dolan-Mullen P. One-to-one—a motivational intervention for resistant pregnant smokers. Addict Behav 2002;27:275-92.

w22. Tappin DM, Lumsden MA, McIntyre D, McKay C, Gilmour WH, Webber R, et al. A pilot study to establish a randomized trial methodology to test the efficacy of a behavioural intervention. Health Educ Res 2000;15:491-502.

w23. Wang WD. Feasibility and effectiveness of a stages-of-change model in cigarette smoking cessation counseling. J Formos Med Assoc 1994;93:752-7.

w24. Tappin DM, Lumsden MA, McKay C, McIntyre D, Gilmour H, Webber R, et al. The effect of home-based motivational interviewing on the smoking behaviour of pregnant women: a pilot randomized controlled efficacy study. Ambul Child Health 2000;6:34-5.